These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effects of pentoxifylline on amikacin-induced nephrotoxicity in rats. Ozer MK; Asci H; Oncu M; Yesilot S; Savran M; Bayram D; Cicek E Ren Fail; 2009; 31(2):134-9. PubMed ID: 19212910 [TBL] [Abstract][Full Text] [Related]
7. Relationship between amikacin blood concentration and ototoxicity in low birth weight infants. Endo A; Nemoto A; Hanawa K; Maebayashi Y; Hasebe Y; Kobayashi M; Naito A; Kobayashi Y; Yamamoto S; Isobe K J Infect Chemother; 2019 Jan; 25(1):17-21. PubMed ID: 30539740 [TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the protective effect of magnesium on amikacin ototoxicity by electrophysiologic tests in guinea pigs]. Bulut E; Yağiz R; Taş A; Uzun C; Yildirim C; Kaymak K; Karasalioğlu AR Kulak Burun Bogaz Ihtis Derg; 2005; 15(3-4):70-7. PubMed ID: 16340296 [TBL] [Abstract][Full Text] [Related]
9. Influence of Spirulina platensis and ascorbic acid on amikacin-induced nephrotoxicity in rabbits. Abdel-Daim MM; Ahmed A; Ijaz H; Abushouk AI; Ahmed H; Negida A; Aleya L; Bungau SG Environ Sci Pollut Res Int; 2019 Mar; 26(8):8080-8086. PubMed ID: 30685861 [TBL] [Abstract][Full Text] [Related]
10. A Prospective Experimental Study on the Protective Effect of Resveratrol against Amikacin-Induced Ototoxicity in Rats. Avcı D; Erkan M; Sönmez MF; Kökoğlu K; Güneş MS; Gündoğdu R; Güleç Ş; Karabulut D J Int Adv Otol; 2016 Dec; 12(3):290-297. PubMed ID: 27810846 [TBL] [Abstract][Full Text] [Related]
11. Ototoxicity caused by once- and twice-daily administration of amikacin in rabbits. Pavlidis P; Nikolaidis V; Gouveris H; Papadopoulos E; Kekes G; Kouvelas D Int J Pediatr Otorhinolaryngol; 2010 Apr; 74(4):361-4. PubMed ID: 20089318 [TBL] [Abstract][Full Text] [Related]
13. The nephroprotective properties of taurine-amikacin treatment in rats are mediated through HSP25 and TLR-4 regulation. Madbouly N; Azmy A; Salama A; El-Amir A J Antibiot (Tokyo); 2021 Sep; 74(9):580-592. PubMed ID: 34253885 [TBL] [Abstract][Full Text] [Related]
14. Protective effect of trimetazidine on amikacin-induced ototoxicity in rats. Aksoy F; Dogan R; Ozturan O; Eren SB; Veyseller B; Pektas A; Hüseyinbas Ö Int J Pediatr Otorhinolaryngol; 2014 Apr; 78(4):663-9. PubMed ID: 24582075 [TBL] [Abstract][Full Text] [Related]
15. Once-daily dosing of amikacin for treatment of Lee H; Sohn YM; Ko JY; Lee SY; Jhun BW; Park HY; Jeon K; Kim DH; Kim SY; Choi JE; Moon IJ; Shin SJ; Park HJ; Koh WJ Int J Tuberc Lung Dis; 2017 Jul; 21(7):818-824. PubMed ID: 28633708 [TBL] [Abstract][Full Text] [Related]
17. Circadian variation in amikacin clearance and its effects on efficacy and toxicity in mice with and without immunosuppression. Hosokawa H; Nyu S; Nakamura K; Mifune K; Nakano S Chronobiol Int; 1993 Aug; 10(4):259-70. PubMed ID: 8403069 [TBL] [Abstract][Full Text] [Related]
18. Dose-dependent dual effect of melatonin on ototoxicity induced by amikacin in adult rats. Erdem T; Ozturan O; Iraz M; Miman MC; Olmez E Eur Arch Otorhinolaryngol; 2005 Apr; 262(4):314-21. PubMed ID: 15170574 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Mitoquinone for Protecting Against Amikacin-Induced Ototoxicity in Guinea Pigs. Dirain CO; Ng MRAV; Milne-Davies B; Joseph JK; Antonelli PJ Otol Neurotol; 2018 Jan; 39(1):111-118. PubMed ID: 29194212 [TBL] [Abstract][Full Text] [Related]
20. [In the search for effective and safe dose of amikacin in patients with chronic kidney disease]. Gomółka M; Szamotulska K; Rymarz A; Brodowska-Kania D; Dubchak I; Piechota W; Jurkiewicz D; Niemczyk S Pol Merkur Lekarski; 2014 Apr; 36(214):240-4. PubMed ID: 24868895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]